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Introduction
Non-adherence	to	medication	
is	a	common	challenge	among	
patients	and	can	contribute	to	
poor	treatment	outcomes	and	
wastage	healthcare	resources	
[1].	
Alzheimer's	disease	is	a	
progressive	age-related	
neurodegenerative	disease	
that	involves	insidiously	
progressive	memory	
impairment	[7].
Introduction	
(Cont’d)
• Cognitive	impairment	is	the	major	symptom	of	Alzheimer's	at	the	early	stage.
• Cognitive	impairment	in	patients	with	mild	Alzheimer’s	disease	often	times	require	medication	management	to	prevent	forgetfulness	due	to	the	diversity	of	medication	involved	in	the	treatment.
7/5/17 4
Introduction	
(Cont’d)
• The	programmability	and	intelligibility	of	modern	electronic	systems	and	Information	and	Communication	Technology	(ICT)	can	be	exploited	to	assist	older	people	in	maintaining	healthy	and	independent	living.	
Introduction	
(Cont’d)
• Mobile	applications	are	increasingly	being	integrated	into	health	care	system	for	disease	surveillance,	appointment	reminders,	disease	outbreak	alerts,	health	education,	and	remote	access	to	patient	records.	This	is	mostly	referred	to	as	mobile	Health	(mHealth).	
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Research	Aim
•This	work	aimed	at	developing	an	intelligent	assistive	mHealth	system	to	facilitate	medication	adherence	in	elderly	patients	with	Alzheimer’s	disease.
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Research	Aim
•The	system	ensures	medication	adherence	by	creating	audiovisual	alert	for	the	user	with	‘memory	loss’	disability	to	take	the	right	doses	of	medication	at	required	frequency.	
7/5/17 8
System	Design	Method
•The complete system design comprises ofdifferent units including:
§Microcontroller (PIC16F877A) ;
§Liquid Crystal Display (LCD);
§Real-time clock chip;
§Communication protocol;
§Alarm sounder; and
§GSMmodule.
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System	Design	Method	(Cont’d)
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Figure	1:	Circuit	Design	of	Smart	Assistive	mHealth	System
System	Implementation
The	PIC16F877A
microcontroller	is	clocked	
with	a	12	MHz	crystal	
oscillator	for	the	generation	
of	the	pulses	that	determines	
the	rate	at	which	information	
is	processed.
The	design	
incorporates	
(DS1307)	a	real-time	
clock	chip,	for	
accurate	timing.	
The	drug	prescription	
dosage	and	time	
intervals	are	entered	
into	the	device	via	
the	matrix	keypad.
System	
Implementation	
(Cont’d)
• When	the	set	time	is	reached,	the	alarm	buzz	and	the	drug	prescription	information	is	displayed	via	the	LCD	with	the	correct	dosage	as	retrieved	from	the	24CXX	memory	chip.	
• The	drug	prescriptions	are	keyed	in	by	the	physician	and	the	medication	schedule	is	stored	in	non-volatile	memory	of	the	system.	
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System	Implementation	(Cont’d)
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Figure	2:	Complete	Smart	Assistive	mHealth	System
System	
Implementa
tion	(Cont’d)
• At	the	set	time,	the	Liquid	Crystal	Display	(LCD)	unit	shows	the	drug	to	be	taken	in	the	right	dosage.	
• The	buzzer	in	the	electronic	device	provides	a	sound	effect	to	get	the	attention	of	the	patient.	
System	
Implementation	
(Cont’d)
• In	case	of	non-adherence,	the	system	automatically	send	a	text	message	to	the	physician	via	the	Short	Messaging	Service	(SMS)	using	the	integrated	Global	System	for	Mobile	Communications	(GSM)	module	and	Subscriber	Identity	Module	(SIM)	in	the	system.	
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System	Implementation	(Cont’d)
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Figure	3:	Internal	Circuitry	of	System	Implementation
Conclusion
• The	programmability	and	intelligibility	of	modern	electronic	systems	and	Information	and	Communication	Technology	(ICT)	was	exploited	to	solve	the	problem	of	non-adherence	to	medication	caused	by	cognitive	impairment	in	elderly	patients	with	Alzheimer’s	disease.	
Conclusion
• An	intelligent	assistive	mHealth	system	was	designed	and	implemented	to	achieve	medication	management	by	preventing	forgetfulness	due	to	the	diversity	of	medication	involved	in	the	treatment	of	Alzheimer’s	disease.
7/5/17 18
Conclusion
• The	developed	system	provides	a	cost-effective	solution	for	patients	with	minimum	literacy	to	conveniently	manage	their	medications,	taking	the	right	dosage	of	medicine	at	the	prescribed	time	as	automated	by	the	system.	
Conclusion
• In	future	work,	we	plan	to	miniaturize	this	system	into	a	wearable	device	for	optimal	performance.
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